"Key Drivers Impacting Executive Summary Intravenous Nucleic Acid Therapeutics Market Size and Share CAGR Value The global intravenous nucleic acid therapeutics market size was valued at USD 1.60 billion in 2024 and is expected to reach USD 2.76 billion by 2032, at a CAGR of 7.07% during the forecast period The credible Intravenous Nucleic Acid...

The oryzenin market is undergoing a dynamic transformation as demand for sustainable and plant-based protein sources continues to grow. As a protein derived from rice, oryzenin offers a hypoallergenic, gluten-free alternative to traditional animal and soy-based proteins, making it an increasingly popular choice for consumers seeking cleaner labels and allergen-free nutrition. One of the key...